Company / Assets per Share
CRISPR Therapeutics AG Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$26.42
FY2025
5-year range
$26.42 / $37.23
FY2021-FY2025
Trend
-5.7%
vs FY2024
Sector context
#46 of 212
Health Care
What the data says
CRISPR Therapeutics AG's assets per share of $26.42 is higher than 78% of companies in the Health Care sector (FY2025). Assets per Share has declined for 4 consecutive years, from $37.23 in FY2021 to $26.42 in FY2025.
Based on SEC 10-K filings.
26.42 in FY2025 with a 5-year CAGR of -2.6%. Top quartile in the Health Care sector.
Declined from $28.40 to $26.42 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -3.2%
- 5-Year CAGR
- -2.6%
- 10-Year CAGR
- -
Sector benchmark
-91.0% below sector average
Key checks
Key Insights
- CRISPR Therapeutics AG's assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 5.7% year-over-year.
- Ranks #46 out of 212 companies in the Health Care sector.
- Peak assets per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.42 | -5.7% |
| FY2024 | $28.01 | -1.4% |
| FY2023 | $28.40 | -2.5% |
| FY2022 | $29.13 | -21.7% |
| FY2021 | $37.23 | +23.8% |
| FY2020 | $30.07 | +46.2% |
| FY2019 | $20.57 | +70.8% |
| FY2018 | $12.05 | +76.3% |
| FY2017 | $6.83 | -89.1% |
| FY2016 | $62.40 | +97.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026